Russell Investments Group Ltd. increased its holdings in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 52.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,406 shares of the medical technology company’s stock after purchasing an additional 6,990 shares during the period. Russell Investments Group Ltd.’s holdings in Hill-Rom were worth $1,927,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Flagship Harbor Advisors LLC purchased a new position in shares of Hill-Rom during the second quarter worth $173,000. CAPROCK Group Inc. purchased a new position in shares of Hill-Rom during the third quarter worth $211,000. CIBC Asset Management Inc purchased a new position in shares of Hill-Rom during the second quarter worth $203,000. Point72 Hong Kong Ltd raised its holdings in shares of Hill-Rom by 88.2% during the second quarter. Point72 Hong Kong Ltd now owns 2,503 shares of the medical technology company’s stock worth $219,000 after purchasing an additional 1,173 shares during the last quarter. Finally, First Citizens Bank & Trust Co. purchased a new position in shares of Hill-Rom during the third quarter worth $269,000. 82.59% of the stock is owned by hedge funds and other institutional investors.

In other Hill-Rom news, SVP Andreas G. Frank sold 7,454 shares of Hill-Rom stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total value of $713,795.04. Following the completion of the transaction, the senior vice president now owns 27,224 shares of the company’s stock, valued at $2,606,970.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.90% of the stock is currently owned by insiders.

HRC has been the subject of several recent research reports. Barclays initiated coverage on shares of Hill-Rom in a report on Monday, October 15th. They set an “equal weight” rating and a $95.00 target price for the company. ValuEngine raised shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, November 6th. Zacks Investment Research cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a report on Wednesday, November 14th. UBS Group initiated coverage on shares of Hill-Rom in a report on Tuesday, November 27th. They issued a “buy” rating and a $115.00 price objective for the company. Finally, Raymond James lifted their price objective on shares of Hill-Rom from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Monday, November 5th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $103.33.

HRC opened at $96.04 on Wednesday. Hill-Rom Holdings, Inc. has a fifty-two week low of $78.16 and a fifty-two week high of $99.81. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.74 and a quick ratio of 1.30. The firm has a market capitalization of $6.52 billion, a price-to-earnings ratio of 20.81, a PEG ratio of 1.38 and a beta of 0.94.

Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Friday, November 2nd. The medical technology company reported $1.63 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.12. Hill-Rom had a net margin of 8.86% and a return on equity of 21.10%. The company had revenue of $759.20 million during the quarter, compared to analysts’ expectations of $750.90 million. During the same quarter in the previous year, the company earned $1.32 earnings per share. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. As a group, equities analysts anticipate that Hill-Rom Holdings, Inc. will post 5.13 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 31st. Shareholders of record on Friday, December 14th will be issued a $0.20 dividend. The ex-dividend date is Thursday, December 13th. This represents a $0.80 dividend on an annualized basis and a yield of 0.83%. Hill-Rom’s payout ratio is 16.84%.

ILLEGAL ACTIVITY NOTICE: “Russell Investments Group Ltd. Acquires 6,990 Shares of Hill-Rom Holdings, Inc. (HRC)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/russell-investments-group-ltd-acquires-6990-shares-of-hill-rom-holdings-inc-hrc/2662573.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: How is inflation measured?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.